For the Inventor, By the Inventor

Enter assignee name

San Antonio, undefined

Bionumerik Pharmaceuticals, Inc.

USPTO Granted Patents = 91

CIPO Patents = 20

EPO Patents = 18

Trademarks = 2

Forward Citations = 600

Loading Chart...

Loading Chart...

33 inventors (with patents filed for the assignee):

Frederick H Hausheer (74 out of 83 patents)

Kochat Haridas (28 out of 28 patents)

Dhanabalan Murali (18 out of 18 patents)

4. Harry Kochat (17 out of 17 patents)

5. Dasharatha Gauravaram Reddy (17 out of 17 patents)

6. Thomas J Dodd (11 out of 11 patents)

7. Qiuli Huang (10 out of 10 patents)

8. Xinghai Chen (8 out of 8 patents)

9. Seetharamulu Peddaiahgari (8 out of 11 patents)

10. Kesavaram Narkunan (5 out of 7 patents)

11. Pavankumar Nv Petluru (5 out of 5 patents)

12. Zejun Xiao (4 out of 4 patents)

13. Aulma Parker (4 out of 6 patents)

14. Peddaiahgari Seetharamulu (4 out of 4 patents)

15. Frederick Herman Hausheer (4 out of 4 patents)

Core Competencies:

Karenitecin

Cancer Patient Survival

Dithio-Containing Compounds

Chemoprotective Methods

Platinum Complexes

Camptothecin Analogs

Disulfide Salts

Toxicity Reduction

Antineoplastic Agents

Heavy Metal Poisoning

Diabetic Neuropathy

Atherosclerosis Treatment

91 patents: Sort by Forward Citations

1. 10413538 - Administration of karenitecin for the treatment of platinum and/or taxane chemotherapy-resistant or -refractory advanced ovarian cancer (2019-09-17),

2. 9320760 - Compositions and methods of use of compounds to increase cancer patient survival time (2016-04-26),

3. 9023805 - Increasing cancer patient survival time by administration of dithio-containing compounds (2015-05-05),

4. 8722886 - Methods for the total chemical synthesis of enantiomerically-pure 7-(2'-trimethylsilyl)ethyl camptothecin (2014-05-13),

5. 8710095 - Drugs for prophylaxis or mitigation of taxane-induced neurotoxicity (2014-04-29),

6. 8569265 - Deuterated analogs of (4S)-4-ethyl-4-hydroxy-11-[2- (trimethylsilyl)ethyl]-1H-pyrano[3', 4′:6,7] indolizino [1,2-b]quinoline-3,14(4H, 12H)-dione and methods of use thereof (2013-10-29),

7. 8143236 - Chemoprotective methods (2012-03-27),

8. 8026227 - Chemoprotective methods and compositions (2011-09-27),

9. 7829541 - Compounds and methods for reducing undesired toxicity of chemotherapeutic agents (2010-11-09),

10. 7829540 - Compounds and methods for reducing undesired toxicity of chemotherapeutic agents (2010-11-09),

11. 7829539 - Compounds and methods for reducing undesired toxicity of chemotherapeutic agents (2010-11-09),

12. 7829538 - Compounds and methods for reducing undesired toxicity of chemotherapeutic agents (2010-11-09),

13. 7829117 - Compounds and methods for reducing undesired toxicity of chemotherapeutic agents (2010-11-09),

14. 7777060 - Platinum analogs with bis-nitrile-containing ligands (2010-08-17),

15. 7759488 - Monoazole ligand platinum analogs (2010-07-20),

BioNumerik Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to discovering, developing, and commercializing novel cancer therapies. With a strong focus on precision medicine, BioNumerik is committed to improving the lives of patients suffering from various types of cancer. The company's innovative approach combines cutting-edge research, advanced technologies, and strategic collaborations to bring groundbreaking therapies to the market.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

91 Patents

#1 in San Antonio

#3,961 in unknown

#8,185 in the World

San Antonio, undefined

Bionumerik Pharmaceuticals, Inc.

Forward Citations = 600

33 inventors:

Frederick H Hausheer (74 out of 83 patents)

Kochat Haridas (28 out of 28 patents)

Dhanabalan Murali (18 out of 18 patents)

4. Harry Kochat (17 out of 17 patents)

5. Dasharatha Gauravaram Reddy (17 out of 17 patents)

Please report any incorrect information to support@idiyas.com

Loading…